Harnessing Synergistic Interplay of Twisted and Planar Structures for the Development of NIR-II Phototheranostic Agents
Developing phototheranostic agents capable of simultaneous cancer diagnosis and therapy, particularly those emitting in the second near-infrared region (NIR-II, 1000-1700 nm), offers considerable prospects. However, achieving efficient fluorescence imaging (FLI) and heat generation for photothermal therapy (PTT) by NIR-II organic dyes remains a challenge primarily due to inadequate photon absorption and competitive energy dissipation pathways. Herein, we employed a molecular design strategy termed "planar core + twisted periphery" to develop a NIR-II phototheranostic agent, 4TPE-TB. This molecule features a coplanar central core to enhance intramolecular conjugation and four highly twisted peripheral rotors to suppress detrimental intermolecular stacking. 4TPE-TB exhibits high molar absorptivity (4.0 × 10<sup>4</sup> M<sup>-1</sup> cm<sup>-1</sup>), excitation at long wavelengths (980 nm), and desirable fluorescence and photothermal performance, superior to its analogs synthesized using previous molecular strategies. By formulating 4TPE-TB into nanoparticles, we successfully achieved high-precision NIR-II FLI and efficient PTT in cancer models. And we find out the dual role of the nanoparticles in direct tumor ablation and immune system activation, reinforcing their potential as a powerful therapeutic platform for cancer treatment. This work highlights a successful design rationale of NIR-II phototheranostic agents, offering the potential to enhance the precision and efficacy of cancer diagnostics and treatments.
Authors
- Ryan T. K. Kwok (ORCID: https://orcid.org/0000-0002-6866-3877)
- Jianquan Zhang (ORCID: https://orcid.org/0000-0003-4528-9824)
- Peikun Xin
- Huilin Xie (ORCID: https://orcid.org/0000-0001-6685-5464)
- Junyi Cai (ORCID: https://orcid.org/0000-0003-3826-3052)
- Guorui Jin (ORCID: https://orcid.org/0000-0002-8494-9541)
- Jacky W. Y. Lam
- Wenjing Liu (ORCID: https://orcid.org/0000-0003-1829-8194)
- Rongyuan Zhang
- Feng Xu (ORCID: https://orcid.org/0000-0003-4351-0222)
- Shi‐Bo Cheng (ORCID: https://orcid.org/0000-0002-4131-2540)
- Ben Zhong Tang (ORCID: https://orcid.org/0000-0002-0293-964X)
- Zhen Tian (ORCID: https://orcid.org/0000-0001-8714-811X)
- Ying Peng (ORCID: https://orcid.org/0009-0002-5017-6656)
- Rufan Mo
Institutions
- Ministry of Education of the People's Republic of China (CN)
- Hong Kong University of Science and Technology (HK)
- State Administration of Traditional Chinese Medicine of the People's Republic of China (CN)
- Chinese University of Hong Kong, Shenzhen (CN)
- Xi'an Jiaotong University (CN)
Publication Details
- Journal
- ACS Nano
- Published
- 2025-10-27
- DOI
- https://doi.org/10.1021/acsnano.5c04254
- Citations
- 3
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 2.02